This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Katherine M Nyswaner: Innovator in Kinase Inhibitors
Introduction
Katherine M Nyswaner is an inventor based in Keedysville, MD (US). She has made significant contributions to the field of kinase inhibitors, focusing on developing compounds that can potentially treat diseases characterized by the overexpression of specific kinases. Although she currently holds no granted patents, her work in this area is noteworthy.
Latest Patent Applications
Katherine M Nyswaner has filed several patent applications that highlight her innovative research. One of her latest applications is for "MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE." This application discloses compounds that inhibit kinase activity and may be used to treat diseases associated with the overexpression of mixed lineage kinases (MLKs). The compounds are described to have a specific structure, including stereoisomers, tautomers, or pharmaceutically acceptable salts.
Another significant application is for "LZK-TARGETING DEGRADERS AND METHODS OF USE." This application presents leucine zipper-bearing kinase (LZK) targeted degraders, which are designed to inhibit LZK activity and potentially degrade LZK. The compounds are formulated to treat diseases characterized by LZK overexpression.
Conclusion
Katherine M Nyswaner is an innovative inventor whose work in kinase inhibitors shows promise for future medical applications. Her latest patent applications reflect her commitment to advancing research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile